Or simply a result of them putting the time and money into the bigger US market...?
Printable View
We might all get an opportunity to better clarify over wine and canapés;
I’ve noticed a difference of opinion between CS and DD multiple times in the media, CS quotes the five year goal as being US$100M in gross revenues, DD as NZ$100M in revenues.
If one allows for an exchange rate of 0.85 and considers COGS as per the 2011 capital raising documents, the difference in NZD is $100M versus $145M.
Perhaps the Chairman likes to ratchet the pressure and the CEO likes to play it down.
I’d just prefer they had a quiet chat, guarantee guidance will come up at the AGM.
https://www.facebook.com/PacificEdge...ed_target_id=0
Anything out of Australia?
They have been there longer than the states and have a bigger population than NZ
http://www.pacificedgedx.com/news-an...opt-cxbladder/
Like MidCentral DHB, which began using Cxbladderdetect in June, BOP urologists will use Cxbladderdetect to evaluate patients presenting with blood in the urine (haematuria) as part of their clinical regime. This new strategy is expected to involve local GPs (the patient’s primary point of contact when symptoms occur) using Cxbladderdetect to help prioritise those patients who need to be seen urgently. They will also be able to identify low risk patients who do not require a full clinical work-up for bladder cancer, saving the public health system considerable associated expense, not to mention the inconvenience to the patients.
If they are successful in getting GP's into using cxbladder rather than just hospitals/larger health providers I would expect sales to start increasing exponentially in NZ - I'm not saying that's going to start happening soon. But, if GP's are using it to diagnose patients and advise whether they need further treatment/expert care at hospitals, rather than initally referring patients to hospitals for further tests, I would think the word of mouth effect between GP's will be quite strong
Apologies, it was over 2,000 user programme tests total in 2012/13 and 2013/14 not 2,000 US user programme tests. Certainly, 700 to 800 patients were involved in the US many of whom would have been tested more than once, I shall go back and amend my post.
http://www.pacificedge.co.nz/assets/...esentation.pdf
Attachment 5739
there are 4 DHBs signed up.
some GPs will refer pts to private clinics for tests for haematurea, and these are sub contracted to the DHB, LIKE IN BOP DHB. GPs are unlikly to use it, they do the simple haematurea test and refer to specialists for close investigations.
In October Pacific Edge told us that Cxbladder(triage) would be launched as a new product in 2014 Q2 (calendar year guidance once again), so in April/May/June, anytime now, tap, tap, ....
“Pacific Edge’s on-going development programme includes clinical and User Programmes to validate Cxbladder(triage) a new product positioned to enable clinicians to segregate patients who have presented to the clinician with haematuria, who do not have bladder cancer”.
And, as we know a 400 patient user programme for micro haematuria segregation is completing at present. Hopefully, Cxbladder(triage) will deliver a specificity of the same or better than that of NPM22(bladder check) at 96%.
I’ve not a medical background but would appreciate some help from those whom do.
Presumably, under certain diagnostic criteria haematuria patients for whom an initial Cxbladder(detect) test has resulted in a negative outcome for bladder cancer may then be provided with an additional Cxbladder(triage) test as a second stage tool for specificity screening.
Has anyone a feel for the relative rate of occurrence for which Cxbladder(triage) would be required ?
Attachment 5741
Bobcat, you really must keep up.
Please go to the website for Pacificedge and read their announcements. Think you will find that under the hub announcement that Auckland, Waitemata, Counties Manukau and Canterbury are all included as of Feb 10.
And here you are trading the things.
All said in the nicest possible way without rancour or malice
Noah Fence